Health
Scientists are finally ready to roll out malaria vaccines after 30 years in development Bloomberg reports.
According to the World Health Organization, the malaria vaccinations will be carried out in Africa starting this month.
The vaccine during its trials prevented four in 10 malaria cases among children who received four doses in a large study.
GlaxoSmithKline Plc invested $1 billion in the development of the vaccine, meant to tackle the mosquito-borne disease that kills at least half a million people annually. It comes at a time when malaria is making a come back after declining for many years.
The malaria parasite’s uncanny ability to resist drugs and insecticides due to its complicated genes is making efforts to eliminate the disease more difficult.
Additionally, research into the vaccine is struggling to secure more international funding.
01:05
Uganda to receive $1.7 billion of US funding under new health deal
Go to video
WHO condemns airstrikes that killed 114 in Sudan
01:11
Malaria deaths, cases surged in 2024 with gains at stake - Report
02:09
Toxic smoke chokes Conakry community as residents plead for government action
01:07
Congolese authorities declare end of Ebola outbreak in Kasai
01:00
Tehran's severe pollution forces school closures and limits traffic